Author(s)

Hemant Deepak Shewade^1*, Arun M. Kokane², Akash Ranjan Singh², Manoj Verma³, Malik Parmar⁴, Sanjay Singh Chahar², Manoj Tiwari², Sheeba Naz Khan³, Mukesh Nagar², Sanjai Kumar Singh², Pradeep Kumar Mehra², Ajay M. V. Kumar^1,5

¹International Union against Tuberculosis and Lung Disease (The Union), South-East Asia Office, New Delhi, India.
²Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences (AIIMS), Bhopal, India.
³State TB cell, Department of Health and Family Welfare, Bhopal, India.
⁴World Health Organization, Country Office in India, New Delhi, India.
⁵International Union against Tuberculosis and Lung Disease (The Union), Paris, France.

Revised national tuberculosis control programme in India has limited co-hort-wise information about what happens to patients diagnosed with multidrug resistant TB (MDR-TB). We determined the pre-treatment loss to follow-up (non-initiation of treatment by programme within 6 months of diagnosis) and time from diagnosis to treatment initiation in Bhopal district, central India (2014). Pre-treatment loss to follow-up was 13% (0.95 CI: 7%, 23%), not significantly different from the national estimates (18%) and median time to initiate treatment was seven days, lower than that reported elsewhere in the country. Bhopal was performing well with reference to time to treatment initiation in programmatic settings.

Multidrug-Resistant Tuberculosis, Operational Research, Pre-Treatment Attrition, Diagnosis and Treatment Pathway, Initial Loss to Follow-Up

Shewade, H. , Kokane, A. , Singh, A. , Verma, M. , Parmar, M. , Chahar, S. , Tiwari, M. , Khan, S. , Nagar, M. , Singh, S. , Mehra, P. and Kumar, A. (2017) Treatment Initiation among Patients with Multidrug Resistant Tuberculosis in Bhopal District, India. Journal of Tuberculosis Research, 5, 237-242. doi: 10.4236/jtr.2017.54025.